agilon health (NYSE:AGL) Stock Price Down 5.7%

agilon health, inc. (NYSE:AGL) fell 5.7% on Monday . The company traded as low as $6.16 and last traded at $6.17. 1,866,494 shares changed hands during trading, a decline of 65% from the average session volume of 5,345,199 shares. The stock had previously closed at $6.54.

Wall Street Analyst Weigh In

AGL has been the topic of a number of recent analyst reports. Citigroup assumed coverage on agilon health in a research report on Monday, April 22nd. They issued a “neutral” rating and a $6.00 target price on the stock. Robert W. Baird assumed coverage on shares of agilon health in a report on Thursday, May 30th. They set a “neutral” rating and a $6.00 price objective for the company. Baird R W upgraded shares of agilon health to a “hold” rating in a research note on Thursday, May 30th. Truist Financial lifted their price target on agilon health from $6.40 to $6.50 and gave the stock a “hold” rating in a research note on Friday, May 24th. Finally, Barclays assumed coverage on agilon health in a research report on Wednesday, March 6th. They set an “underweight” rating and a $5.00 price target on the stock. One research analyst has rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $9.03.

agilon health Stock Down 6.9 %

The firm has a market cap of $2.50 billion, a price-to-earnings ratio of -8.67 and a beta of 0.60. The stock’s 50 day moving average is $5.91 and its 200 day moving average is $6.78. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.03. agilon health had a negative return on equity of 26.15% and a negative net margin of 5.67%. The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.62 billion. Analysts forecast that agilon health, inc. will post -0.34 EPS for the current year.

Hedge Funds Weigh In On agilon health

Large investors have recently made changes to their positions in the business. Scotia Capital Inc. boosted its holdings in agilon health by 1.3% during the fourth quarter. Scotia Capital Inc. now owns 132,576 shares of the company’s stock worth $1,664,000 after buying an additional 1,741 shares in the last quarter. Nomura Asset Management Co. Ltd. lifted its holdings in shares of agilon health by 31.5% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 8,969 shares of the company’s stock valued at $113,000 after purchasing an additional 2,149 shares during the last quarter. Checchi Capital Advisers LLC boosted its position in shares of agilon health by 1.0% in the 4th quarter. Checchi Capital Advisers LLC now owns 257,537 shares of the company’s stock valued at $3,232,000 after purchasing an additional 2,475 shares during the period. Swiss National Bank increased its stake in agilon health by 0.6% in the 1st quarter. Swiss National Bank now owns 602,800 shares of the company’s stock worth $3,677,000 after purchasing an additional 3,400 shares in the last quarter. Finally, Quest Partners LLC acquired a new stake in agilon health during the 4th quarter worth about $45,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.